bioAffinity Technologies, Inc. - 8-K Filing
CyPath® Lung test sales grew over 100% through Q3 2026 compared to the same period in 2025. (Items: 8.01 Other Events, 9.01 Financial Statements and Exhibits)
Tickers: $BIAF
More Regulatory news
- SAGA COMMUNICATIONS INC - 8-K Filing
- NextBoat Inc. - 8-K Filing
- CIVISTA BANCSHARES, INC. - 8-K Filing
- RF Acquisition Corp II - 10-Q Filing
- ORASURE TECHNOLOGIES INC - 10-Q Filing
- Rocket Companies, Inc. - 8-K Filing
- Applied Aerospace & Defense, Inc. - 10-Q Filing
- Palomar Holdings, Inc. - 8-K Filing
- UNITED GUARDIAN INC - 10-Q Filing
- Dare Bioscience, Inc. - 8-K Filing